SSRIS IN ANXIOUS-AGITATED DEPRESSION - A POST-HOC ANALYSIS OF 279 PATIENTS

被引：32

作者：

FILTEAU, MJ

BARUCH, P

LAPIERRE, YD

BAKISH, D

BLANCHARD, A

机构：

[1] CTR RECH LAVAL ROBERT GIFFARD,BEAUPORT,PQ G1J 2G3,CANADA

[2] ROYAL OTTAWA HOSP,INST MENTAL HLTH RES,OTTAWA,ON K1Z 7K4,CANADA

来源：

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1995年 / 10卷 / 01期

关键词：

ANTIDEPRESSANTS; ANXIETY; DEPRESSION; SSRIS;

D O I：

10.1097/00004850-199503000-00007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A post-hoc analysis of nine controlled antidepressant trials examined the intensity of the initial anxiety and agitation of depressed patients improved by SSRIs compared with depressed patients improved by norepinephrine (NE) reuptake inhibitors, mixed NE/serotonin reuptake inhibitors and placebo. We report that SSRI responders were more anxious-agitated than NE reuptake inhibitor responders, suggesting a preferential efficacy of SSRIs in agitated depression.

引用

页码：51 / 54

页数：4

共 50 条

[41] Association of a prehabilitation program with anxiety and depression before colorectal surgery: a post hoc analysis of the pERACS randomized controlled trial
Taha, Anas
Taha-Mehlitz, Stephanie
Staartjes, Victor E.
Lunger, Fabian
Gloor, Severin
Unger, Ines
Mungo, Giuseppe
Tschuor, Christoph
Breitenstein, Stefan
Gingert, Christian
LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (05) : 1553 - 1561
[42] Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis
Wang, Mingqia
Zhang, Bin
Zhou, Yangling
Wang, Chengyu
Zheng, Wei
Liu, Weijian
Zhan, Yanni
Lan, Xiaofeng
Ning, Yuping
PHARMACOLOGICAL REPORTS, 2021, 73 (02) : 594 - 603
[43] Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study
Papakostas, George I.
Fava, Maurizio
Freeman, Marlene P.
Shelton, Richard C.
Thase, Michael E.
Jha, Manish K.
Trivedi, Madhukar H.
Dirks, Bryan
Liu, Keith
Stankovic, Srdjan
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020, 35 (06) : 313 - 321
[44] Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study
Tsai, Joyce
Thase, Michael E.
Mao, Yongcai
Ng-Mak, Daisy
Pikalov, Andrei
Loebel, Antony
CNS SPECTRUMS, 2017, 22 (02) : 236 - 245
[45] Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: Post-hoc analysis of a randomised controlled trial
Noah, Lionel
Dye, Louise
Bois De Fer, Beatrice
Mazur, Andre
Pickering, Gisele
Pouteau, Etienne
STRESS AND HEALTH, 2021, 37 (05) : 1000 - 1009
[46] Impact of prenatal maternal depression on gestational length post hoc analysis of a randomized clinical trial
Davis, Elysia Poggi
Demers, Catherine H.
Deer, Lillybelle
Gallop, Robert J.
Hoffman, M. Camille
Grote, Nancy
Hankin, Benjamin L.
ECLINICALMEDICINE, 2024, 72
[47] NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorder
Johe, Karl K.
Kay, Gary
Kumar, Santosh
Burdick, Katherine E.
McIntyre, Roger S.
Papakostas, George, I
Fava, Maurizio
ANNALS OF CLINICAL PSYCHIATRY, 2020, 32 (03) : 182 - 196
[48] Adjunctive Brexpiprazole (OPC-34712) in Patients with MDD and Anxiety Symptoms: Results from Post-Hoc Analyses of Two Pivotal Studies
Kostic, Dusan
Weiller, Emmanuelle
Zhang, Peter
Eramo, Anna
Duffy, Ruth A.
Baker, Ross A.
Weiss, Catherine
NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S163 - S163
[49] Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study
Lisinski, Alexander
Hieronymus, Fredrik
Naeslund, Jakob
Nilsson, Staffan
Eriksson, Elias
NEUROPSYCHOPHARMACOLOGY, 2020, 45 (03) : 553 - 560
[50] Post-traumatic growth, depression and anxiety among hemodialysis patients: a latent profile analysis
Song, Qianqian
Yuan, Tongshuang
Xu, Zhonggao
Xu, Ying
Wu, Meiyan
Hou, Jie
Fei, Junsong
Mei, Songli
PSYCHOLOGY HEALTH & MEDICINE, 2025,

← 1 2 3 4 5 →